The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 487 participants.
Also called NCT02352402
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 487 participants
- Sponsor
- Registry
-
NCT02352402 -
2014-002142-50
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Unknown status
Technical summary
Registry record NCT02352402. Randomized; quadruple masking; primary purpose treatment. Start 2015-03 (registry gives no type); primary completion 2020-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery
- Acronym
- POPular CABG
- Condition
- Coronary Artery Disease
- Condition
- Stable Angina
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Placebo
- Lead sponsor
- J.M. ten Berg
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct02352402- Content hash
dc30db0147e4a76b67d89f71f1b2916fed53978c9bb7c5febcc14cc4f327c5dc